Stromal Gene Therapy Mediates Prolonged Protection Against Corneal Neovascularization Induced by an Aggressive Angiogenic Insult
Human Gene Therapy · 2025
DOI: 10.1089/hum.2024.248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, 2025. Verfasst von Mark Basche und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Gene Therapy and Regenerative Medicine, King's College London, London, UK. Hauptthemen laut MEDLINE: Genetic Therapy, Corneal Neovascularization, Corneal Stroma. Die Arbeit nennt 69 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Gene Therapy and Regenerative Medicine, King's College London, London, UK.
- Department of Ophthalmology, Guy's & St. Thomas' Hospitals NHS Foundation Trust, London, UK.
- NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
- UCL Institute of Ophthalmology, London, United Kingdom.
ORCID-Profile: Mark Basche
Zitieren
APA
Basche, M., Robbie, S., Larkin, D. F. P., Smith, A. J., Pearson, R. A., & Ali, R. R. (2025). Stromal Gene Therapy Mediates Prolonged Protection Against Corneal Neovascularization Induced by an Aggressive Angiogenic Insult. Human Gene Therapy. https://doi.org/10.1089/hum.2024.248
Vancouver
Basche M, Robbie S, Larkin DFP, Smith AJ, Pearson RA, Ali RR. Stromal Gene Therapy Mediates Prolonged Protection Against Corneal Neovascularization Induced by an Aggressive Angiogenic Insult. Human Gene Therapy. 2025. doi:10.1089/hum.2024.248
BibTeX
@article{Basche2025,
author = {Basche, Mark and Robbie, Scott and Larkin, D Frank P and Smith, Alexander J and Pearson, Rachael A and Ali, Robin R},
title = {Stromal Gene Therapy Mediates Prolonged Protection Against Corneal Neovascularization Induced by an Aggressive Angiogenic Insult},
journal = {Human Gene Therapy},
year = {2025},
doi = {10.1089/hum.2024.248}
}
EUVIMED